The Efficacy of CIK-Based Immunotherapies for Advanced Solid Tumors

Technology in Cancer Research and Treatment - United States
doi 10.1177/1533034616659163
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Rational Combination of Immunotherapies With Clinical Efficacy in Mice With Advanced Cancer

Cancer immunology research
Cancer ResearchImmunology
2015English

Antiangiogenic Targeting Liposomes Increase Therapeutic Efficacy for Solid Tumors

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2009English

A Chimeric Switch-Receptor Targeting PD1 Augments the Efficacy of Second-Generation CAR T Cells in Advanced Solid Tumors

Cancer Research
Cancer ResearchOncology
2016English

Pre-Clinical Development of Listeria-Based Nanovaccines as Immunotherapies for Solid Tumours: Insights From Melanoma

OncoImmunology
OncologyAllergyImmunology
2018English

Safety and Efficacy of Durvalumab (MEDI4736) in Various Solid Tumors

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2018English

A Phase I Study of NLG919 for Adult Patients With Recurrent Advanced Solid Tumors

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

Molecular Imaging Biomarkers for Cell-Based Immunotherapies

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2017English

Safety and Tolerability of AZD5363 in Japanese Patients With Advanced Solid Tumors

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2016English

Onivyde for the Therapy of Multiple Solid Tumors

OncoTargets and Therapy
OncologyPharmacology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy